Nearly 1 million people received Chinese covid-19 vaccine: Sinopharm

This is the inside of the trial of a Chinese vaccine 3:58

Hong Kong . –– Almost one million people received an experimental COVID-19 vaccine developed by Chinese pharmaceutical company Sinopharm, as part of an emergency use program authorized by Beijing, the company president said.

So far, no serious adverse effects have been reported in recipients of the Chinese vaccine. This was indicated by Sinopharm this Wednesday in an article published on the WeChat platform, citing President Liu Jingzhen.

“Under emergency use, we have now applied it to almost a million people. We have not received reports of serious adverse reactions and only a few had some mild symptoms, ”Liu said.

Liu noted that the vaccine was administered to Chinese construction workers, diplomats and students who traveled to more than 150 countries around the world during the pandemic. None of them have reported an infection, he added.

There are two candidate vaccines for Sinopharm

On November 6, Liu indicated that there were 56,000 people who received emergency vaccines against covid-19 and then went abroad.

“For example, a transnational company has 99 employees in one of its offices abroad, of which 81 were vaccinated. And then an outbreak broke out in the office. 10 of the 18 people who were not vaccinated were infected and none of the vaccinated were infected, “he said.

Two laboratories are in the final stretch for the vaccine 0:59

He also mentioned that Sinopharm had separately conducted phase 3 clinical trials for the Chinese vaccine involving nearly 60,000 people in 10 countries. Among them, the United Arab Emirates, Bahrain, Egypt, Jordan, Peru and Argentina. CNN has not yet seen the results of these trials.

Sinopharm has two candidate vaccines. It is not clear which COVID-19 vaccine Liu was referring to.

China has been granting companies authorization for rush-use vaccines using experimental drugs for months. In June, the Chinese company CanSino Biologics announced that it had been granted special authorization to administer its experimental vaccine to the People’s Liberation Army.

Experimental vaccines in China

Since July, Chinese drugmakers have given experimental vaccines to people working in “high-risk” professions. This, within the framework of the emergency use program, which allows candidate vaccines to be used on a limited scale before their safety and efficacy have been fully demonstrated in clinical trials.

Experimental COVID-19 vaccines have even been reportedly offered to the public in parts of China. Which has caused some citizens to rush across the country to get a fix.

Sinopharm’s comments come after Pfizer announced the first results of its phase 3 trials for a coronavirus vaccine on Wednesday. According to Pfizer, the vaccine is 95% effective in preventing infections, even in older adults. It also didn’t cause serious safety problems, according to the drugmaker. A day earlier, Moderna announced that its vaccine against covid-19 was 94.5% effective.

Pfizer requested emergency use authorization from the US Food and Drug Administration on Friday for its vaccine.

Dr. Anthony Fauci, America’s leading infectious disease expert, said that the Pfizer and Moderna vaccines demonstrated extraordinary efficacy.

“That is extraordinary,” said Fauci. “That’s almost at the level of what we see with the measles (vaccine), which is 98% effective.”

CNN’s Beijing headquarters contributed to this article.